Saint-Gobain Performance Plastics buys Twin Bay Medical

Published: 4-Dec-2012
Packaging Finance Pharmaceutical

Adds flexible tube retainers and single-use components for biopharmaceuticals to portfolio


Saint-Gobain Performance Plastics of Aurora, Ohio, US has completed the acquisition of Twin Bay Medical, expanding its capabilities as a full service provider to the biopharmaceutical industry.

Twin Bay Medical is a Michigan-based manufacturer of BarbLock flexible tube retainers and single-use components for biopharmaceuticals manufacturing.

The company’s production facility in Williamsburg, Michigan, its development organisation and all of its employees are included in the deal.

‘The acquisition of Twin-Bay Medical enables us to continue to bring innovative solutions to the market, especially for single-use biopharmaceutical manufacturing for which Twin Bay Medical has consistently been developing new and unique products to meet the challenges of this new industry,’ said Michael Cahill, VP of Saint-Gobain Performance Plastics’ fluid systems division.

‘Twin Bay Medical and Saint-Gobain share the same passion for customer service, with a strong emphasis on quality and reliability.’

Twin Bay Medical's founder, Al Werth, will continue to work with Saint-Gobain Performance Plastics.

Saint-Gobain Performance Plastics employs 4,500 people in 16 countries. Products include films, foams, coated fabrics, bearings, seals and fluid systems.

  • Companies:
  • Saint Gobain
See more

You may also like

Manufacturing

Saint-Gobain Performance Plastics acquires Applied Bioprocess Containers

Read more
Taking advantage of its expertise in the design and manufacture of bioprocess containers

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020
  2. Building strong foundations for a resilient and planet-friendly future Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI Pharma Services, to find out how this leading CDMO is tackling climate science, workforce empowerment, responsible waste management and supply chain security
  3. The evolution of the pharma industry: From reactive to disruptive Globally, the pharma industry has witnessed waves of changes during the last century; we have evolved, writes Ajit Kanetkar, Head, Process Technology, ACG, from maintaining a conservative outlook and being solely reactive to disease and healthcare issues to having a radical and disruptive approach
  4. Lonza aims to tackle bias concerns during blinded clinical trials Lonza has introduced an over-encapsulation product aimed at tackling concerns around bias during blinded clinical trials
  5. Small molecules: big market opportunities The rapid rise of biologic drugs in recent years has been accompanied by a market narrative that suggests that innovation and new treatments will be fuelled by breakthroughs in this area, leading to a decline in the small molecule pipeline. This is far from true, notes Kevin Cook, Chief Executive Officer at Sterling Pharma Solutions; both are increasing and small molecule drugs continue to be a mainstay of many drug development portfolios

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Manufacturing

Saint-Gobain Performance Plastics acquires Applied Bioprocess Containers

Taking advantage of its expertise in the design and manufacture of bioprocess containers
Packaging

Saint-Gobain Performance Plastics buys American Fluoroseal Corporation

Expands into vessels or bags used in cell culture applications
Packaging

SGD launches the EasyLyo vial for biodrugs

<p>SGD, previously known as Saint-Gobain DesjonquEres, a French manufacturer of glass containers for pharmaceuticals and perfumery/cosmetics, has developed the EasyLyo, a type 1 moulded vial, to meet growing demand for small-capacity containers for biodrugs.</p>
Packaging

Saint-Gobain DesjonquEres achieves ISO 15378 for all production facilities

Saint-Gobain DesjonquEres\'s French production sites have achieved ISO 15378 certification
Drug Delivery

Adult vaccination programmes deliver significant socio-economic benefits, study finds

The study shows that adult immunisation programmes return 19x their initial investment, which could ease the pressure on health systems
Sustainability

Building strong foundations for a resilient and planet-friendly future

Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI Pharma Services, to find out how this leading CDMO is tackling climate science, workforce empowerment, responsible waste management and supply chain security
Sustainability

Dickson achieves ISO 14001 certification

ISO 14001 certification highlights a companies' long-term efforts to manage its environmental impact
Subscribe now